---
layout: default
title: Rotigotine
description: "Rotigotine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚åˆæ­¥è­‰æ“šç­‰ç´š L4ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 151
evidence_level: L4
indication_count: 10
---

# Rotigotine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L4</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Rotigotineï¼šå¾å¸•é‡‘æ£®æ°ç—‡åˆ°æ€è¦ºå¤±èª¿ç—‡

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Rotigotine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Rotigotine åŸæœ¬ç”¨æ–¼æ²»ç™‚åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ã€‚TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**æ€è¦ºå¤±èª¿ç—‡ (schizophrenia)** æœ‰æ•ˆï¼Œé€™å€‹é æ¸¬ç²å¾—å¤šç¯‡ PubMed æ–‡ç»æ”¯æŒï¼ŒåŒ…å«ç³»çµ±æ€§å›é¡§åŠè—¥ç†å­¸ç ”ç©¶ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | attention deficit-hyperactivity disorderã€schizophreniaã€polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposisã€faciodigitogenital syndromeã€congenital disorder of glycosylation with defective fucosylationã€retinal dystrophy with or without extraocular anomaliesã€myopia X-linkedã€atypical glycine encephalopathyã€Charcot-Marie-Tooth disease, demyelinating, type 1Gã€myopia 26, X-linked, female-limited |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.996% |
| è­‰æ“šç­‰ç´š | L4 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 12 å¼µ |
| å»ºè­°æ±ºç­– | Worth Exploring |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. attention deficit-hyperactivity disorder</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">100.00%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Rotigotine æ˜¯ä¸€ç¨®ééº¥è§’é¡å¤šå·´èƒºä¿ƒæ•ˆåŠ‘ï¼Œå°æ‰€æœ‰äº”ç¨®å¤šå·´èƒºå—é«”äºå‹ï¼ˆD1-D5ï¼‰éƒ½æœ‰æ´»æ€§ï¼š</p>

<ol>
<li><strong>å»£è­œå¤šå·´èƒºå—é«”ä½œç”¨</strong>ï¼šRotigotine å° D1ã€D2ã€D3ã€D4ã€D5 å—é«”éƒ½æœ‰è¦ªå’ŒåŠ›ï¼Œé€™ç¨®å»£è­œä½œç”¨å¯èƒ½å°æ€è¦ºå¤±èª¿ç—‡çš„è¤‡é›œå¤šå·´èƒºå¤±èª¿æœ‰ç¨ç‰¹å„ªå‹¢ã€‚</li>

<li><strong>è² æ€§ç—‡ç‹€æ²»ç™‚æ½›åŠ›</strong>ï¼šæ€è¦ºå¤±èª¿ç—‡çš„è² æ€§ç—‡ç‹€èˆ‡å‰é¡è‘‰çš®è³ªå¤šå·´èƒºåŠŸèƒ½ä½ä¸‹æœ‰é—œï¼ŒD1 å—é«”ä¿ƒæ•ˆä½œç”¨å¯èƒ½æœ‰åŠ©æ–¼æ”¹å–„ã€‚</li>

<li><strong>æŒçºŒè—¥ç‰©é‡‹æ”¾</strong>ï¼šç©¿çš®è²¼ç‰‡åŠ‘å‹æä¾›ç©©å®šçš„è¡€ä¸­æ¿ƒåº¦ï¼Œå¯èƒ½æ¸›å°‘ç™‚æ•ˆæ³¢å‹•å’Œå‰¯ä½œç”¨ã€‚</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. schizophrenia</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">100.00%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ4 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37221270/" target="_blank">37221270</a></td><td>2023</td><td>Article</td><td>Cell research</td><td>Structural genomics of the human dopamine receptor system.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31688399/" target="_blank">31688399</a></td><td>2019</td><td>Article</td><td>Journal of clinical psychophar</td><td>Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Syste...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25449598/" target="_blank">25449598</a></td><td>2015</td><td>Article</td><td>Biochemical pharmacology</td><td>New functional activity of aripiprazole revealed: Robust antagonism of D2 dopami...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1974516/" target="_blank">1974516</a></td><td>1990</td><td>Article</td><td>European journal of pharmacolo</td><td>The potential antipsychotic activity of the partial dopamine receptor agonist (+...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. faciodigitogenital syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. congenital disorder of glycosylation with defective fucosylation</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. retinal dystrophy with or without extraocular anomalies</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ15 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9416661/" target="_blank">9416661</a></td><td>1997</td><td>Article</td><td>Seminars in ultrasound, CT, an</td><td>Orbital infections.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20127583/" target="_blank">20127583</a></td><td>2010</td><td>Article</td><td>Seminars in neurology</td><td>Pearls: diplopia.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7035111/" target="_blank">7035111</a></td><td>1981</td><td>Article</td><td>Documenta ophthalmologica. Adv</td><td>The Wagner-Stickler syndrome complex.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38249493/" target="_blank">38249493</a></td><td>2023</td><td>Article</td><td>Taiwan journal of ophthalmolog</td><td>Congenital anomalies of lens shape.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22241537/" target="_blank">22241537</a></td><td>2012</td><td>Article</td><td>Klinische Monatsblatter fur Au</td><td>[Congenital ptosis].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24413161/" target="_blank">24413161</a></td><td>2014</td><td>Article</td><td>Journal of neuro-ophthalmology</td><td>Congenital trochlear-oculomotor synkinesis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33447730/" target="_blank">33447730</a></td><td>2020</td><td>Article</td><td>Therapeutic advances in ophtha</td><td>Eye involvement in inherited metabolic disorders.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33806565/" target="_blank">33806565</a></td><td>2021</td><td>Article</td><td>International journal of molec</td><td>Optic Nerve Head and Retinal Abnormalities Associated with Congenital Fibrosis o...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19064847/" target="_blank">19064847</a></td><td>2008</td><td>Article</td><td>Archives of ophthalmology (Chi</td><td>Orbital arteriovenous malformations.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38321238/" target="_blank">38321238</a></td><td>2024</td><td>Article</td><td>Pediatric radiology</td><td>Pediatric orbital lesions: ocular pathologies.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19826317/" target="_blank">19826317</a></td><td>2009</td><td>Article</td><td>Optometry and vision science :</td><td>Variable synergistic divergence.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30196776/" target="_blank">30196776</a></td><td>2018</td><td>Article</td><td>Journal of binocular vision an</td><td>Ophthalmoplegia and Congenital Cranial Dysinnervation Disorders.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30747268/" target="_blank">30747268</a></td><td>2019</td><td>Article</td><td>Neuroradiology</td><td>Neuroradiological and clinical features in ophthalmoplegia.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24932988/" target="_blank">24932988</a></td><td>2014</td><td>Article</td><td>American journal of ophthalmol</td><td>Pathogenesis and treatment of maculopathy associated with cavitary optic disc an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36892533/" target="_blank">36892533</a></td><td>2023</td><td>Article</td><td>Investigative ophthalmology &amp; </td><td>Missense Mutations in MAB21L1: Causation of Novel Autosomal Dominant Ocular BAMD...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. myopia X-linked</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. atypical glycine encephalopathy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. Charcot-Marie-Tooth disease, demyelinating, type 1G</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. myopia 26, X-linked, female-limited</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›ç½²è—¥è¼¸å­—ç¬¬024933è™Ÿ | ç´æ™®æ´›ç©¿çš®è²¼ç‰‡åŠ‘ 2 æ¯«å…‹/24å°æ™‚ | ç©¿çš®è²¼ç‰‡åŠ‘ | åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬024934è™Ÿ | ç´æ™®æ´›ç©¿çš®è²¼ç‰‡åŠ‘ 4 æ¯«å…‹/24å°æ™‚ | ç©¿çš®è²¼ç‰‡åŠ‘ | åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬024935è™Ÿ | ç´æ™®æ´›ç©¿çš®è²¼ç‰‡åŠ‘ 6 æ¯«å…‹/24å°æ™‚ | ç©¿çš®è²¼ç‰‡åŠ‘ | åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬024936è™Ÿ | ç´æ™®æ´›ç©¿çš®è²¼ç‰‡åŠ‘ 8 æ¯«å…‹/24å°æ™‚ | ç©¿çš®è²¼ç‰‡åŠ‘ | åŸç™¼æ€§å¸•é‡‘æ£®æ°ç—‡ |

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è—¥ç‰©äº¤äº’ä½œç”¨

| äº¤äº’ä½œç”¨è—¥ç‰© | åš´é‡ç¨‹åº¦ | ä¾†æº |
|-------------|---------|------|
| Morphine | ä¸­åº¦ | DDInter |
| Metoclopramide | ä¸­åº¦ | DDInter |
| Ethanol | ä¸­åº¦ | DDInter |
| Thalidomide | ä¸­åº¦ | DDInter |
| Promethazine | ä¸­åº¦ | DDInter |
| Codeine | ä¸­åº¦ | DDInter |
| Diphenhydramine | ä¸­åº¦ | DDInter |

### è—¥ç†å­¸æ¨™é¶

| æ¨™é¶ | åŸºå› åç¨± |
|-----|---------|
| D1 receptor | DRD1 |
| D2 receptor | DRD2 |
| D3 receptor | DRD3 |
| D4 receptor | DRD4 |
| D5 receptor | DRD5 |

### ç‰¹æ®Šæ³¨æ„äº‹é …

- **å—œç¡èˆ‡çªç™¼ç¡çœ **ï¼šå¯èƒ½å½±éŸ¿é§•é§›èƒ½åŠ›
- **è¡å‹•æ§åˆ¶éšœç¤™**ï¼šèˆ‡å…¶ä»–å¤šå·´èƒºä¿ƒæ•ˆåŠ‘é¡ä¼¼çš„é¢¨éšª
- **çš®è†šåæ‡‰**ï¼šè²¼ç‰‡éƒ¨ä½å¯èƒ½å‡ºç¾å±€éƒ¨åæ‡‰


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**æ°£å–˜** ğŸŸ¡ Moderate
- å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**å¿ƒè¡€ç®¡ç–¾ç—…** ğŸŸ¡ Moderate
- é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€å£“ã€‚

**Water-Electrolyte Imbalance** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚

**ä½è¡€å£“** ğŸŸ¢ Minor
- éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€å£“ã€‚

**Psychotic Disorders** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚
- å»ºè­°ï¼šé¿å…å¤§é‡æ”å–ã€‚


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šWorth Exploring**

**ç†ç”±ï¼š**
1. å»£è­œå¤šå·´èƒºå—é«”ä½œç”¨æä¾›ç¨ç‰¹çš„è—¥ç†å­¸å„ªå‹¢
2. ç©¿çš®è²¼ç‰‡åŠ‘å‹å¯ç¢ºä¿ç©©å®šè¡€ä¸­æ¿ƒåº¦
3. æ­·å²ç ”ç©¶é¡¯ç¤ºç›¸é—œåŒ–åˆç‰©å…·æœ‰æ½›åœ¨æŠ—ç²¾ç¥ç—…æ´»æ€§
4. ç³»çµ±æ€§å›é¡§æ”¯æŒä¿ƒå¤šå·´èƒºè—¥ç‰©ç”¨æ–¼è² æ€§ç—‡ç‹€
5. å°ç£å·²æœ‰å¤šç¨®åŠ‘é‡è¦æ ¼ä¸Šå¸‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- è‡¨åºŠè©¦é©—è©•ä¼° Rotigotine è²¼ç‰‡è¼”åŠ©æ²»ç™‚æ€è¦ºå¤±èª¿ç—‡è² æ€§ç—‡ç‹€çš„ç™‚æ•ˆ
- ç¢ºå®šæœ€é©åŠ‘é‡ç¯„åœï¼ˆå¯èƒ½èˆ‡å¸•é‡‘æ£®æ°ç—‡ç”¨é‡ä¸åŒï¼‰
- è©•ä¼°èˆ‡æŠ—ç²¾ç¥ç—…è—¥ç‰©ä½µç”¨çš„å®‰å…¨æ€§å’Œäº¤äº’ä½œç”¨

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Aluminum Oxide]({{ "/drugs/aluminum_oxide/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Dl-Alpha-Tocopherol]({{ "/drugs/dl-alpha-tocopherol/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Prednisolone Acetate]({{ "/drugs/prednisolone_acetate/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Acebutolol]({{ "/drugs/acebutolol/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Ritonavir]({{ "/drugs/ritonavir/" | relative_url }}) - è­‰æ“šç­‰ç´š L4

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Rotigotineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/rotigotine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_rotigotine,
  title = {Rotigotineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/rotigotine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
